Clinically active IBD linked to adverse COVID-19 outcomes
(HealthDay)—Clinically active inflammatory bowel disease (IBD) is associated with adverse COVID-19 outcomes, especially in younger and middle-aged adults, according to a study published online Sept. 2
Updated on: May 29,2024
7

Clinically active IBD linked to adverse COVID-19 outcomes
(HealthDay)—Clinically active inflammatory bowel disease (IBD) is associated with adverse COVID-19 outcomes, especially in younger and middle-aged adults, according to a study published online Sept. 2
Updated on:May 29,2024
7
